Preclinical studies showed synergic anti-tumor activity of Rituximab and Fludarabin. Comparison of efficacy of FC with FCR regimens administered in first line therapy and their influence on disease-free and overall survival in patients with B-cell lymphocytic leukemia were the main goals of this retrospective study. It has been demonstrated that inclusion of Rituximab into the FC regi... https://oidwnfm8puvv.aioblogs.com/87843272/the-effect-of-cognitive-task-gait-speed-and-age-on-cognitive-motor-interference-during-walking